Hydroxychloroquine and COVID-19: can we learn from the use of rituximab in systemic lupus erythematosus?

Rituximab (RTX), a chimeric monoclonal anti-CD20 antibody has become part of the standard therapy for patients with CD20-expressing B-cell lymphoma and rheumatoid arthritis. After encouraging results with open studies in systemic lupus erythematosus (SLE), RTX has not shown its effectiveness in rand...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pan Afr Med J
Hlavní autoři: Lekpa, Fernando Kemta, Ngahane, Bertrand Hugo Mbatchou, Njonnou, Sylvain Raoul Simeni, Fouda, Hermine, Halle, Marie Patrice, Njankouo, Yacouba Mapoure, Dzudie, Anastase, Choukem, Simeon Pierre, Luma, Henry Namme
Médium: Artigo
Jazyk:Inglês
Vydáno: The African Field Epidemiology Network 2021
Témata:
Commentary
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8308936/
https://ncbi.nlm.nih.gov/pubmed/34367451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11604/pamj.2021.38.372.29087
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky